CLINICAL_TRIALS
trial_result
· 2013-09-27
Clinical Trial Update: Hydrocortisone for Prevention of Septic Shock [Phase 3]
Summary
Phase 3 trial evaluating hydrocortisone for prevention of septic shock has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Charite University, Berlin, Germany | Conditions: Severe Sepsis | Phase 3 | Status: COMPLETED